Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diseases of the Colon & Rectum
Published in: Diseases of the Colon & Rectum 3/2006

01-03-2006 | Original Contributions

Coexpression of VEGF-C and Cox-2 in Human Colorectal Cancer and its Association With Lymph Node Metastasis

Authors: Labile Togba Soumaoro, M.D., Hiroyuki Uetake, M.D., Ph.D., Yoko Takagi, Satoru Iida, M.D., Ph.D., Tetsuro Higuchi, M.D., Masamichi Yasuno, M.D., Masayuki Enomoto, M.D., Ph.D., Kenichi Sugihara, M.D., Ph.D.

Published in: Diseases of the Colon & Rectum | Issue 3/2006

Login to get access

Purpose

Several lines of experimental evidence indicated that over-expression of vascular endothelial growth factor-C and cyclooxygenase-2 genes promotes angiogenesis and lymphangiogenesis, both of which are essential for the growth and spreading of tumor cells. This study was designed to evaluate the coexpression of vascular endothelial growth factor-C and cyclooxygenase-2 in human colorectal carcinoma to determine their relationships and correlations with lymph node metastasis and prognosis.

Methods

Tissue samples of primary tumors and metastatic lymph nodes from 150 patients undergoing intentionally curative surgical resections for colorectal adenocarcinoma were immunohistochemically examined for vascular endothelial growth factor-C, cyclooxygenase-2, and CD34 expressions. Then, we analyzed their relationships and correlations with clinicopathologic findings and patients' survival time.

Results

The positivity rate of vascular endothelial growth factor-C and cyclooxygenase-2 in the primary tumor was 68 and 72.7 percent, respectively, and in the metastatic lymph nodes was 93.3 and 80 percent, respectively. A significant correlation was found between the expression scores of vascular endothelial growth factor-C and cyclooxygenase-2 (P < 0.0001), and both also were correlated to microvessels density and several clinicopathologic parameters, including primary tumor size, lymph node metastasis, lymphatic invasion, and TNM stage. Patients with vascular endothelial growth factor-C-positive and/or cyclooxygenase-2-positive tumors had a significant shorter survival time than those with negative tumors did. However, in a multivariate analysis, only cyclooxygenase-2 expression was recognized as an independent prognostic factor (P = 0.0412; relative risk ratio, 3.067; 95 percent confidence interval, 1.046–8.994).

Conclusions

These data show that in human colorectal carcinoma, vascular endothelial growth factor-C and cyclooxygenase-2 are coexpressed and significantly associated with lymph node metastasis and prognosis.
Literature
1.
Hawk, ET, Umar, A, Viner, JL 2004Colorectal cancer chemoprevention: an overview of the scienceGastroenterology12614231447CrossRefPubMed
2.
Krishnan, J, Kirkin, V, Steffen, A,  et al. 2003Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent ratsCancer Res63713722PubMed
3.
Voyer, TE, Sigurdson, ER, Hanlon, AL,  et al. 2003Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089J Clin Oncol2129122919PubMed
4.
5.
Su, JL, Shih, JY, Yen, ML,  et al. 2004Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinomaCancer Res64554564PubMed
6.
Skobe, M, Hawighorst, T, Jackson, DG,  et al. 2001Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasisNat Med7192198CrossRefPubMed
7.
Stacker, SA, Caesar, C, Baldwin, ME,  et al. 2001VEGF-D promotes the metastatic spread of tumor cells via the lymphaticsNat Med7186191CrossRefPubMed
8.
Cao, Y, Linden, P, Farnebo, J,  et al. 1998Vascular endothelial growth factor-C induces angiogenesis in vivoProc Natl Acad Sci USA951438914394PubMed
9.
Yonemura, Y, Endo, Y, Fujita, H,  et al. 1999Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancerClin Cancer Res518231829PubMed
10.
Tsurusaki, T, Kanda, S, Sakai, H,  et al. 1999Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasisBr J Cancer80309313CrossRefPubMed
11.
Akagi, K, Ikeda, Y, Miyazaki, M,  et al. 2000Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissuesBr J Cancer83887891CrossRefPubMed
12.
Hashimoto, I, Kodama, J, Seki, N,  et al. 2001Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancerBr J Cancer859397CrossRefPubMed
13.
Masunaga, R, Kohno, H, Dhar, DK,  et al. 2000Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patientsClin Cancer Res640644068PubMed
14.
Cianchi, F, Cortesini, C, Bechi, P,  et al. 2001Up-regulation of cyclooxygenase-2 gene expression correlates with tumor angiogenesis in human colorectal cancerGastroenterology12113391347CrossRefPubMed
15.
Miyata, Y, Koga, S, Kanda, S, Nishikido, M, Hayashi, T, Kanetake, H 2003Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survivalClin Cancer Res917411749PubMed
16.
Soumaoro, LT, Uetake, H, Higuchi, T, Takagi, Y, Enomoto, M, Sugihara, K 2004Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancerClin Cancer Res1084658471CrossRefPubMed
17.
Oshima, M, Dinchuk, JE, Kargman, SL,  et al. 1996Suppression of intestinal polyposis in \({\text{APC}}^{{\Delta 716}} \) knockout mice by inhibition of cyclooxygenase-2 (Cox-2)Cell 87803809CrossRefPubMed
18.
Kawamori, T, Rao, CV, Seibert, K, Reddy, BS 1998Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesisCancer Res58409412PubMed
19.
Yamauchi, T, Watanabe, M, Kubota, T,  et al. 2002Cyclooxygenase-2 expression as a new marker for patients with colorectal cancerDis Colon Rectum4598103CrossRefPubMed
20.
Arinaga, M, Noguchi, T, Takeno, S, Chujo, M, Miura, T, Uchida, Y 2003Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinomaCancer97457464CrossRefPubMed
21.
Denkert, C, Winzer, KJ, Muller, BM,  et al. 2003Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinomaCancer9729782987CrossRefPubMed
22.
Byeon, JS, Jung, HY, Lee, YJ,  et al. 2004Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinomaJ Gastroenterol Hepatol19648654CrossRefPubMed
23.
Seno, H, Oshima, M, Ishikawa, T,  et al. 2002Cyclooxygenase-2 and prostaglandin E2 receptor EP2-dependent angiogenesis in \({\text{APC}}^{{\Delta 716}} \) mouse intestinal polypsCancer Res62506511PubMed
24.
Kyzas, PA, Stefanou, D, Agnantis, NJ 2005Cox-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinomaMod Pathol18153160PubMed
25.
Mandriota, SJ, Jussila, L, Jeltsch, M,  et al. 2001Vascular endothelial growth factor-C- mediated lymphangiogenesis promotes tumour metastasisEMBO J20672682CrossRefPubMed
26.
Tsujii, M, Kawano, S, DuBois, RN 1997Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potentialProc Natl Acad Sci USA9433363340CrossRefPubMed
27.
Tsujii, M, Kawano, S, Tsuji, S, Sawaoka, H, Hori, M, DuBois, RN 1998Cyclooxygenase regulates angiogenesis induced by colon cancer cellsCell93705716CrossRefPubMed
28.
Masferrer, JL, Leahy, KM, Koki, AT,  et al. 2000Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitorsCancer Res6013061311PubMed
29.
Shimizu, K, Kubo, H, Yamaguchi, K,  et al. 2004Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancerCancer Sci95328333CrossRefPubMed
30.
Ogawa, E, Takenaka, K, Yanagihara, K,  et al. 2004Clinical significance of VEGF-C status in tumor cells and stromal macrophages in non-small cell lung cancer patientsBr J Cancer91498503CrossRefPubMed
31.
Tomozawa, S, Tsuno, NH, Sunami, E,  et al. 2000Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis of colorectal cancerBr J Cancer83324328CrossRefPubMed
32.
Vita, F, Orditura, M, Lieto, E,  et al. 2004Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinomaCancer100270278PubMed
33.
Mitsuhashi, A, Suzuka, K, Yamazawa, K, Matsui, H, Seki, K, Sekiya, S 2005Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinomaCancer103724730CrossRefPubMed
34.
Roumen, RM, Slooter, GD, Croiset van Uchelen, FA, Vader Huib, L 2005Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patientsDis Colon Rectum4810701075CrossRefPubMed
Metadata
Title
Coexpression of VEGF-C and Cox-2 in Human Colorectal Cancer and its Association With Lymph Node Metastasis
Authors
Labile Togba Soumaoro, M.D.
Hiroyuki Uetake, M.D., Ph.D.
Yoko Takagi
Satoru Iida, M.D., Ph.D.
Tetsuro Higuchi, M.D.
Masamichi Yasuno, M.D.
Masayuki Enomoto, M.D., Ph.D.
Kenichi Sugihara, M.D., Ph.D.
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 3/2006
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-005-0247-x

Other articles of this Issue 3/2006

Diseases of the Colon & Rectum 3/2006 Go to the issue

Case Reports

Stapled Hemorrhoidopexy: An Alternative Technique for the Treatment of Bleeding Anorectal Varices. Report of a Case

Letters to the Editor

Our View on Fissure Healing Should Be Verified

Original Contributions

A Patient's Race/Ethnicity Does Not Explain the Underuse of Appropriate Adjuvant Therapy in Colorectal Cancer

Original Contributions

Barostat Measurement of Rectal Compliance and Capacity

OriginalPaper

Self-Assessment Quiz: Answers, Critiques, and References

Original Contributions

Efficacy of Anal Fistula Plug vs. Fibrin Glue in Closure of Anorectal Fistulas